Skip to main content
Premium Trial:

Request an Annual Quote

Piper Jaffray , Caroline Stewart, Jacques Essinger

Premium

Piper Jaffray said this week that Caroline Stewart has joined the firm as a vice president and senior health care research analyst covering biotechnology companies. Stewart will be located in Piper Jaffray's New York office.

Stewart joins the firm from Morgan Joseph & Co./IRG, where she served as a senior research analyst covering small- to mid-cap development-stage and early-product biotechnology companies. She has also previously been employed by Leerink Swann/Medacorp, Salomon Smith Barney, and Deutsche Banc Securities. Stewart received her MS in molecular and cell biology and chemistry from Brandeis University.


Trophos this week appointed Jacques Essinger as president of the company's supervisory board.

Essinger has previously served as CEO of Modex Technologies, now Isotis Orthobiology. He holds a MS in physics and a PhD in biomechanics form the Swiss Federal Institute of Technology.

Trophos is a Marseille, France-based drug-discovery firm that uses a phenotypic screening platform to develop preclinical and clinical drug candidates for neurogenerative diseases.

 

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.